90
Participants
Start Date
August 12, 2024
Primary Completion Date
April 1, 2027
Study Completion Date
September 30, 2027
Maintenance at initial treatment sequential as-needed therapy with inhaled budesonide-formoterol(Symbicort 160/4.5) ®）
one inhalation twice daily for 4 weeks maintenance, sequential as-needed for symptom relief (no more than 8 inhalations per day) to 24-week.
as-needed therapy with inhaled budesonide-formoterol (Symbicort 160/4.5) ®）
as-needed for symptom relief (no more than 8 inhalations per day) to 24-week.
Shanghai General Hospital, Shanghai
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
OTHER